A retrievable, dual-chamber stent protects against warm ischemia of donor organs in a model of donation after circulatory death.
Journal
Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
22
06
2021
revised:
27
09
2021
accepted:
03
10
2021
pubmed:
30
11
2021
medline:
20
4
2022
entrez:
29
11
2021
Statut:
ppublish
Résumé
Ischemic injury during the agonal period of donation after circulatory death donors remains a significant barrier to increasing abdominal transplants. A major obstacle has been the inability to improve visceral perfusion, while at the same time respecting the ethics of the organ donor. A retrievable dual-chamber stentgraft could potentially isolate the organ perfusion from systemic hypotension and hypoxia, without increasing cardiac work or committing the donor. Retrievable dumbbell-shaped stents were laser welded from nitinol wire and covered with polytetrafluoroethylene. Yorkshire pigs were assigned to either agonal control or dumbbell-shaped dual-chamber stentgraft. A central lumen maintained aortic flow, while an outer visceral chamber was perfused with oxygenated blood. A 1-hour agonal phase of hypoxia and hypotension was simulated. Stents were removed by simple sheath advancement. Cardiac monitoring, labs, and visceral flow were recorded followed by recovery of the animal to a goal of 48 hours. Cardiac stress did not increase during stent deployment. Visceral pO2 and flow were dramatically improved in stented animal relative to control animals. Five of 7 control animals were killed after renal failure complications, whereas all stent animals survived. Histology confirmed increased ischemic changes among control kidneys compared to stented animals. A dual-chamber stent improved outcomes after a simulated agonal phase. The stent did not increase cardiac work, thus respecting a key ethical consideration. The ability of a dual-chamber stent to prevent ischemia during organ recovery may become a powerful tool to address the critical donor organ shortage.
Sections du résumé
BACKGROUND
Ischemic injury during the agonal period of donation after circulatory death donors remains a significant barrier to increasing abdominal transplants. A major obstacle has been the inability to improve visceral perfusion, while at the same time respecting the ethics of the organ donor. A retrievable dual-chamber stentgraft could potentially isolate the organ perfusion from systemic hypotension and hypoxia, without increasing cardiac work or committing the donor.
METHODS
Retrievable dumbbell-shaped stents were laser welded from nitinol wire and covered with polytetrafluoroethylene. Yorkshire pigs were assigned to either agonal control or dumbbell-shaped dual-chamber stentgraft. A central lumen maintained aortic flow, while an outer visceral chamber was perfused with oxygenated blood. A 1-hour agonal phase of hypoxia and hypotension was simulated. Stents were removed by simple sheath advancement. Cardiac monitoring, labs, and visceral flow were recorded followed by recovery of the animal to a goal of 48 hours.
RESULTS
Cardiac stress did not increase during stent deployment. Visceral pO2 and flow were dramatically improved in stented animal relative to control animals. Five of 7 control animals were killed after renal failure complications, whereas all stent animals survived. Histology confirmed increased ischemic changes among control kidneys compared to stented animals.
CONCLUSION
A dual-chamber stent improved outcomes after a simulated agonal phase. The stent did not increase cardiac work, thus respecting a key ethical consideration. The ability of a dual-chamber stent to prevent ischemia during organ recovery may become a powerful tool to address the critical donor organ shortage.
Identifiants
pubmed: 34839934
pii: S0039-6060(21)01035-7
doi: 10.1016/j.surg.2021.10.040
pmc: PMC8960345
mid: NIHMS1759752
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1100-1107Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB022591
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL098036
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Transplantation. 2014 Feb 15;97(3):258-64
pubmed: 24492420
Surgery. 2016 Oct;160(4):892-901
pubmed: 27524434
Am J Transplant. 2014 Dec;14(12):2846-54
pubmed: 25283987
J Trauma Acute Care Surg. 2020 Aug;89(2):320-328
pubmed: 32740640
Transplant Proc. 2019 Jan - Feb;51(1):12-19
pubmed: 30655135
Int J Surg. 2020 Oct;82S:36-43
pubmed: 32389812
Anaesthesia. 2020 Sep;75(9):1215-1222
pubmed: 32430909
Intensive Care Med. 2019 Mar;45(3):310-321
pubmed: 30725134
J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):646-656
pubmed: 30119820
Ann Surg. 2016 Feb;263(2):211-6
pubmed: 26181480
Ann Surg. 2007 Nov;246(5):844-52
pubmed: 17968178
Curr Opin Organ Transplant. 2015 Apr;20(2):127-32
pubmed: 25719900
Am J Transplant. 2017 Aug;17(8):2165-2172
pubmed: 28141909
J Trauma Acute Care Surg. 2017 Aug;83(2):249-255
pubmed: 28452874
Chest. 1991 Jul;100(1):207-12
pubmed: 2060344
J Biomed Mater Res B Appl Biomater. 2019 May;107(4):911-923
pubmed: 30176119
Am J Transplant. 2020 Jun;20(6):1508-1512
pubmed: 31913567
Transplant Proc. 2019 Mar;51(2):475-478
pubmed: 30879571
Ann Surg. 1975 Nov;182(5):576-84
pubmed: 1103757
Ann Surg. 2020 Nov;272(5):751-758
pubmed: 32833758
J Hepatol. 2019 Apr;70(4):658-665
pubmed: 30582980
J Intensive Care Med. 2008 Sep-Oct;23(5):303-12
pubmed: 18647817
Clin Transplant. 2019 Nov;33(11):e13724
pubmed: 31585486
Transplantation. 2019 May;103(5):938-943
pubmed: 30063694
Transpl Int. 2016 Jul;29(7):771-9
pubmed: 26581182
Transpl Int. 2020 Jan;33(1):76-88
pubmed: 31482628